CVS Health Quarterly Income Statements Chart
Quarterly
|
Annual
CVS Health Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-09-27 | 2008-06-28 | 2008-03-29 | 2007-09-29 | 2007-06-30 | 2007-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenues: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| products | 60,607,000,000 | 57,669,000,000 | 61,911,000,000 | 59,674,000,000 | 56,212,000,000 | 53,724,000,000 | 65,154,000,000 | 61,298,000,000 | 60,539,000,000 | 58,147,000,000 | 59,657,000,000 | 57,643,000,000 | 56,794,000,000 | 52,522,000,000 | 53,973,000,000 | 51,853,000,000 | 50,525,000,000 | 47,387,000,000 | 49,592,000,000 | 47,738,000,000 | 46,355,000,000 | 47,003,000,000 | 49,213,000,000 | 47,149,000,000 | 45,531,000,000 | 43,343,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| premiums | 34,195,000,000 | 32,820,000,000 | 30,913,000,000 | 30,925,000,000 | 30,667,000,000 | 30,391,000,000 | 25,075,000,000 | 24,657,000,000 | 25,108,000,000 | 24,352,000,000 | 21,436,000,000 | 21,003,000,000 | 21,260,000,000 | 21,631,000,000 | 19,205,000,000 | 18,984,000,000 | 18,983,000,000 | 18,960,000,000 | 17,615,000,000 | 17,182,000,000 | 16,927,000,000 | 17,640,000,000 | 15,510,000,000 | 15,539,000,000 | 15,791,000,000 | 16,282,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| services | 3,626,000,000 | 3,579,000,000 | 4,131,000,000 | 4,279,000,000 | 3,961,000,000 | 3,868,000,000 | 3,316,000,000 | 3,532,000,000 | 3,000,000,000 | 2,445,000,000 | 2,430,000,000 | 2,312,000,000 | 2,436,000,000 | 2,505,000,000 | 3,059,000,000 | 2,711,000,000 | 2,819,000,000 | 2,453,000,000 | 2,099,000,000 | 1,932,000,000 | 1,875,000,000 | 1,950,000,000 | 1,960,000,000 | 1,859,000,000 | 1,816,000,000 | 1,772,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| net investment income | 487,000,000 | 520,000,000 | 755,000,000 | 550,000,000 | 394,000,000 | 454,000,000 | 268,000,000 | 277,000,000 | 274,000,000 | 334,000,000 | 323,000,000 | 201,000,000 | 146,000,000 | 168,000,000 | 367,000,000 | 246,000,000 | 289,000,000 | 297,000,000 | 248,000,000 | 204,000,000 | 184,000,000 | 162,000,000 | 206,000,000 | 263,000,000 | 293,000,000 | 249,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| total revenues | 98,915,000,000 | 94,588,000,000 | 97,710,000,000 | 95,428,000,000 | 91,234,000,000 | 88,437,000,000 | 93,813,000,000 | 89,764,000,000 | 88,921,000,000 | 85,278,000,000 | 83,846,000,000 | 81,159,000,000 | 80,636,000,000 | 76,826,000,000 | 76,604,000,000 | 73,794,000,000 | 72,616,000,000 | 69,097,000,000 | 69,554,000,000 | 67,056,000,000 | 65,341,000,000 | 66,755,000,000 | 66,889,000,000 | 64,810,000,000 | 63,431,000,000 | 61,646,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| operating costs: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cost of products sold | 54,005,000,000 | 51,057,000,000 | 55,268,000,000 | 52,948,000,000 | 49,998,000,000 | 48,073,000,000 | 57,419,000,000 | 54,688,000,000 | 53,536,000,000 | 51,455,000,000 | 51,728,000,000 | 50,365,000,000 | 49,290,000,000 | 45,509,000,000 | 46,378,000,000 | 45,011,000,000 | 43,520,000,000 | 40,894,000,000 | 42,452,000,000 | 40,940,000,000 | 40,242,000,000 | 40,347,000,000 | 42,065,000,000 | 40,437,000,000 | 38,970,000,000 | 37,247,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| health care costs | 31,317,000,000 | 29,135,000,000 | 29,543,000,000 | 29,922,000,000 | 27,853,000,000 | 27,803,000,000 | 22,518,000,000 | 21,499,000,000 | 21,782,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| operating expenses | 11,212,000,000 | 11,022,000,000 | 10,421,000,000 | 10,557,000,000 | 10,338,000,000 | 10,290,000,000 | 10,503,000,000 | 9,876,000,000 | 9,873,000,000 | 9,580,000,000 | 10,084,000,000 | 9,606,000,000 | 9,171,000,000 | 9,876,000,000 | 10,065,000,000 | 9,210,000,000 | 8,869,000,000 | 8,922,000,000 | 9,433,000,000 | 8,471,000,000 | 8,668,000,000 | 8,563,000,000 | 8,654,000,000 | 8,595,000,000 | 8,042,000,000 | 8,250,000,000 | 4,913,000,000 | 4,796,000,000 | 4,627,000,000 | 4,818,000,000 | 4,787,000,000 | 4,611,000,000 | 4,675,000,000 | 4,665,000,000 | 4,568,000,000 | 4,572,000,000 | 4,330,000,000 | 4,140,000,000 | 4,032,000,000 | 4,312,000,000 | 4,222,000,000 | 4,116,000,000 | 3,918,000,000 | 4,122,000,000 | 3,874,000,000 | 3,868,000,000 | 3,883,000,000 | 3,994,000,000 | 3,833,000,000 | 3,741,000,000 | 3,709,000,000 | 3,598,000,000 | 3,594,000,000 | 3,605,000,000 | 3,440,000,000 | 3,540,000,000 | 3,519,000,000 | 3,336,000,000 | 3,445,800,000 | 3,452,400,000 | 2,934,400,000 | 2,895,100,000 | 2,924,100,000 | 2,848,700,000 | |||||
| total operating costs | 96,534,000,000 | 91,214,000,000 | 95,342,000,000 | 94,596,000,000 | 88,189,000,000 | 86,166,000,000 | 90,440,000,000 | 86,074,000,000 | 85,687,000,000 | 81,832,000,000 | 80,228,000,000 | 85,090,000,000 | 76,067,000,000 | 73,336,000,000 | 74,375,000,000 | 70,733,000,000 | 68,290,000,000 | 65,520,000,000 | 67,030,000,000 | 63,807,000,000 | 60,661,000,000 | 63,297,000,000 | 63,852,000,000 | 61,882,000,000 | 60,099,000,000 | 58,956,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| operating income | 2,381,000,000 | 3,374,000,000 | 2,368,000,000 | 832,000,000 | 3,045,000,000 | 2,271,000,000 | 3,373,000,000 | 3,690,000,000 | 3,234,000,000 | 3,446,000,000 | 3,618,000,000 | -3,931,000,000 | 4,569,000,000 | 3,490,000,000 | 2,229,000,000 | 3,061,000,000 | 4,326,000,000 | 3,577,000,000 | 2,524,000,000 | 3,249,000,000 | 4,680,000,000 | 3,458,000,000 | 3,037,000,000 | 2,928,000,000 | 3,332,000,000 | 2,690,000,000 | |||||||||||||||||||||||||||||||||||||||||||
| yoy | -21.81% | 48.57% | -29.80% | -77.45% | -5.84% | -34.10% | -6.77% | -193.87% | -29.22% | -1.26% | 62.31% | -228.42% | 5.62% | -2.43% | -11.69% | -5.79% | -7.56% | 3.44% | -16.89% | 10.96% | 40.46% | 28.55% | |||||||||||||||||||||||||||||||||||||||||||||||
| qoq | -29.43% | 42.48% | 184.62% | -72.68% | 34.08% | -32.67% | -8.59% | 14.10% | -6.15% | -4.75% | -192.04% | -186.04% | 30.92% | 56.57% | -27.18% | -29.24% | 20.94% | 41.72% | -22.31% | -30.58% | 35.34% | 13.86% | 3.72% | -12.12% | 23.87% | ||||||||||||||||||||||||||||||||||||||||||||
| operating margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| interest expense | 763,000,000 | 785,000,000 | 758,000,000 | 752,000,000 | 732,000,000 | 716,000,000 | 690,000,000 | 693,000,000 | 686,000,000 | 589,000,000 | 552,000,000 | 566,000,000 | 583,000,000 | 586,000,000 | 608,000,000 | 602,000,000 | 636,000,000 | 657,000,000 | 678,000,000 | 731,000,000 | 765,000,000 | 733,000,000 | 734,000,000 | 747,000,000 | 772,000,000 | 782,000,000 | 453,000,000 | 475,000,000 | 473,000,000 | 297,000,000 | 245,000,000 | 247,000,000 | 252,000,000 | 242,000,000 | 253,000,000 | 280,000,000 | 283,000,000 | 276,000,000 | 261,000,000 | 166,000,000 | 134,000,000 | 131,000,000 | 153,000,000 | 158,000,000 | 158,000,000 | 135,000,000 | 122,000,000 | 126,000,000 | 126,000,000 | 160,000,000 | 134,000,000 | 132,000,000 | 132,000,000 | 147,000,000 | 155,000,000 | 148,000,000 | 134,000,000 | 137,000,000 | 135,000,000 | 128,000,000 | 122,800,000 | 127,900,000 | 142,100,000 | 112,700,000 | 114,700,000 | 130,900,000 | 127,500,000 | 105,900,000 | 63,900,000 |
| other income | -29,000,000 | -28,000,000 | -25,000,000 | -25,000,000 | -24,000,000 | -25,000,000 | -22,000,000 | -22,000,000 | -22,000,000 | -22,000,000 | -43,000,000 | -41,000,000 | -43,000,000 | -42,000,000 | -38,000,000 | -49,000,000 | -45,000,000 | -50,000,000 | -53,000,000 | -54,000,000 | -45,000,000 | -54,000,000 | -31,000,000 | -31,000,000 | -31,000,000 | -31,000,000 | 1,000,000 | 3,000,000 | 3,000,000 | 2,000,000 | 192,000,000 | 7,000,000 | 7,000,000 | ||||||||||||||||||||||||||||||||||||
| income before income tax provision | 1,647,000,000 | 2,617,000,000 | 2,126,000,000 | 105,000,000 | 2,337,000,000 | 1,580,000,000 | 2,570,000,000 | 2,879,000,000 | 3,109,000,000 | -4,456,000,000 | 4,029,000,000 | 2,946,000,000 | 1,570,000,000 | 2,145,000,000 | 3,735,000,000 | 2,970,000,000 | 1,225,000,000 | 1,806,000,000 | 3,960,000,000 | 2,779,000,000 | 2,334,000,000 | 2,133,000,000 | 2,591,000,000 | 1,939,000,000 | 1,899,000,000 | -2,065,000,000 | 1,470,000,000 | 1,364,750,000 | 2,062,000,000 | 1,863,000,000 | 1,534,000,000 | 1,471,000,000 | 2,463,000,000 | 1,528,000,000 | 1,893,000,000 | 1,540,750,000 | 2,070,000,000 | 2,096,000,000 | 1,998,000,000 | 1,372,000,000 | 1,572,000,000 | 2,050,000,000 | 1,866,000,000 | 1,363,500,000 | 2,039,000,000 | 1,842,000,000 | 1,573,000,000 | 1,132,000,000 | 1,680,000,000 | 1,576,000,000 | 1,272,000,000 | 984,000,000 | 1,429,000,000 | 1,342,000,000 | 1,177,000,000 | 1,347,000,000 | 1,366,000,000 | 1,282,000,000 | |||||||||||
| income tax provision | 634,000,000 | 835,000,000 | 503,000,000 | 34,000,000 | 569,000,000 | 456,000,000 | 656,000,000 | 737,000,000 | 1,068,000,000 | 633,000,000 | 274,000,000 | 558,000,000 | 944,000,000 | 746,000,000 | 241,000,000 | 587,000,000 | 974,000,000 | 767,000,000 | 590,000,000 | 604,000,000 | 660,000,000 | 512,000,000 | 509,000,000 | 497,000,000 | 472,000,000 | -478,000,000 | 777,000,000 | 766,000,000 | 572,000,000 | 1,046,000,000 | 921,000,000 | 604,000,000 | 746,000,000 | 953,000,000 | 833,000,000 | 824,000,000 | 777,000,000 | 868,000,000 | 624,000,000 | 804,000,000 | 737,000,000 | 812,000,000 | 779,000,000 | 720,000,000 | 617,000,000 | 666,000,000 | 669,000,000 | 610,000,000 | 496,000,000 | 711,000,000 | 562,000,000 | 526,000,000 | 464,000,000 | 528,000,000 | 544,000,000 | 510,000,000 | 420,000,000 | 582,800,000 | 491,600,000 | 534,700,000 | 539,900,000 | 490,700,000 | 454,100,000 | 480,300,000 | 263,700,000 | ||||
| net income | 1,013,000,000 | 1,782,000,000 | 1,623,000,000 | 71,000,000 | 1,768,000,000 | 1,124,000,000 | 2,047,000,000 | 2,265,000,000 | 1,914,000,000 | 2,142,000,000 | 2,300,000,000 | -3,409,000,000 | 2,961,000,000 | 2,313,000,000 | 1,296,000,000 | 1,587,000,000 | 2,791,000,000 | 2,224,000,000 | 975,000,000 | 1,219,000,000 | 2,986,000,000 | 2,012,000,000 | 1,744,000,000 | 1,529,000,000 | 1,931,000,000 | 1,427,000,000 | 1,390,000,000 | -2,563,000,000 | 998,000,000 | 3,287,000,000 | 1,285,000,000 | 1,098,000,000 | 953,000,000 | 1,707,000,000 | 1,541,000,000 | 924,000,000 | 1,147,000,000 | 1,499,000,000 | 1,247,000,000 | 1,272,000,000 | 1,221,000,000 | 1,321,000,000 | 948,000,000 | 1,246,000,000 | 1,129,000,000 | 1,261,000,000 | 1,254,000,000 | 1,121,000,000 | 956,000,000 | 1,129,000,000 | 1,006,000,000 | 965,000,000 | 775,000,000 | 1,063,000,000 | 867,000,000 | 815,000,000 | 712,000,000 | 808,000,000 | 821,000,000 | 770,000,000 | 1,021,300,000 | ||||||||
| yoy | -42.70% | 58.54% | -20.71% | -96.87% | -7.63% | -47.53% | -11.00% | -166.44% | -35.36% | -7.39% | 77.47% | -314.81% | 6.09% | 4.00% | 32.92% | 30.19% | -6.53% | 10.54% | -44.09% | -20.27% | 54.63% | 41.00% | 25.47% | -159.66% | 93.49% | -56.59% | 8.17% | -333.42% | 4.72% | 92.56% | -16.61% | 18.83% | -16.91% | 13.88% | 23.58% | -27.36% | -6.06% | 13.47% | 31.54% | 2.09% | 8.15% | 4.76% | -24.40% | 11.15% | 18.10% | 11.69% | 24.65% | 16.17% | 23.35% | 6.21% | 16.03% | 18.40% | 8.85% | 31.56% | 5.60% | 5.84% | -30.28% | ||||||||||||
| qoq | -43.15% | 9.80% | 2185.92% | -95.98% | 57.30% | -45.09% | -9.62% | 18.34% | -10.64% | -6.87% | -167.47% | -215.13% | 28.02% | 78.47% | -18.34% | -43.14% | 25.49% | 128.10% | -20.02% | -59.18% | 48.41% | 15.37% | 14.06% | -20.82% | 35.32% | 2.66% | -154.23% | -356.81% | -69.64% | 155.80% | 17.03% | 15.22% | -44.17% | 10.77% | 66.77% | -19.44% | -23.48% | 20.21% | -1.97% | 4.18% | -7.57% | 39.35% | -23.92% | 10.36% | -10.47% | 0.56% | 11.86% | 17.26% | -15.32% | 12.23% | 4.25% | 24.52% | -27.09% | 22.61% | 6.38% | 14.47% | -11.88% | -1.58% | 6.62% | -24.61% | |||||||||
| net income margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net (income) loss attributable to noncontrolling interests | 8,000,000 | 21,000,000 | 16,000,000 | 2,000,000 | 2,000,000 | -7,000,000 | 10,000,000 | 11,000,000 | -2,000,000 | 5,000,000 | -11,000,000 | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to cvs health | 1,021,000,000 | 1,779,000,000 | 1,644,000,000 | 87,000,000 | 1,770,000,000 | 1,113,000,000 | 2,046,000,000 | 2,261,000,000 | 1,901,000,000 | 2,136,000,000 | 2,302,000,000 | -3,416,000,000 | 2,951,000,000 | 2,312,000,000 | 1,306,000,000 | 1,598,000,000 | 2,783,000,000 | 2,223,000,000 | 973,000,000 | 1,224,000,000 | 2,975,000,000 | 2,007,000,000 | 1,747,000,000 | 1,530,000,000 | 1,936,000,000 | 1,421,000,000 | 1,390,000,000 | -2,563,000,000 | 998,000,000 | 3,287,000,000 | 1,285,000,000 | 1,098,000,000 | 952,000,000 | 1,707,000,000 | 1,540,000,000 | 924,000,000 | 1,146,000,000 | 1,498,000,000 | 1,246,000,000 | ||||||||||||||||||||||||||||||
| net income per share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 0.81 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 | 1.48 | 1.66 | 0.353 | -2.6 | 2.25 | 1.76 | 1.253 | 1.21 | 2.11 | 1.69 | 1.185 | 0.93 | 2.27 | 1.54 | 1.09 | 0.86 | 1.04 | 1.13 | 1.08 | 0.96 | |||||||||||||||||||||||||||||||||||||||||
| diluted | 0.8 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.75 | 1.48 | 1.65 | 0.35 | -2.6 | 2.23 | 1.74 | 1.245 | 1.2 | 2.1 | 1.68 | 1.18 | 0.93 | 2.26 | 1.53 | 1.09 | 0.86 | 1.04 | 1.12 | 1.07 | 0.95 | |||||||||||||||||||||||||||||||||||||||||
| weighted-average shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 1,266 | 1,261 | 1,259 | 1,259 | 1,256 | 1,260 | 1,285 | 1,287 | 1,283 | 1,283 | 1,315 | 1,313 | 1,312 | 1,321 | 1,319 | 1,313 | 1,310 | 1,309 | 1,306 | 1,298 | 1,070 | 1,092 | 1,124 | 1,128 | 1,180 | ||||||||||||||||||||||||||||||||||||||||||||
| diluted | 1,270 | 1,264 | 1,262 | 1,259 | 1,259 | 1,267 | 1,290 | 1,290 | 1,287 | 1,291 | 1,315 | 1,321 | 1,328 | 1,329 | 1,327 | 1,322 | 1,315 | 1,314 | 1,312 | 1,302 | 1,075 | 1,099 | 1,132 | 1,136 | 1,190 | ||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to noncontrolling interests | -3,000,000 | -11,000,000 | -5,750,000 | -4,000,000 | -13,000,000 | -6,000,000 | -10,000,000 | -1,000,000 | -8,000,000 | -1,000,000 | -5,000,000 | 1,000,000 | -6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| restructuring charges | 10,000,000 | 1,169,000,000 | 11,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loss on assets held for sale | 349,000,000 | 12,000,000 | 2,480,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| dividends declared per share | 0.499 | 0.665 | 0.665 | 0.665 | 0.605 | 0.605 | 0.605 | 0.605 | 0.55 | 0.55 | 0.55 | 0.55 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.375 | 0.5 | 0.5 | 0.5 | 0.319 | 0.425 | 0.425 | 0.425 | 0.263 | 0.35 | 0.35 | 0.35 | 0.206 | 0.275 | 0.275 | 0.275 | ||||||||||||||||||||||||||
| restructuring charge | 496,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| opioid litigation charges | 99,000,000 | 5,220,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income before income tax benefit | 2,117,000,000 | 3,019,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income tax benefit | 536,750,000 | 754,000,000 | 163,500,000 | -1,047,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| opioid litigation charge | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| benefit costs | 20,448,000,000 | 18,305,000,000 | 17,419,000,000 | 17,606,000,000 | 17,951,000,000 | 16,574,000,000 | 16,081,000,000 | 15,901,000,000 | 15,704,000,000 | 15,145,000,000 | 14,396,000,000 | 11,751,000,000 | 14,387,000,000 | 13,133,000,000 | 12,850,000,000 | 13,087,000,000 | 13,459,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| goodwill impairment | 431,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loss on early extinguishment of debt | 89,000,000 | 363,000,000 | 674,000,000 | 766,000,000 | 79,000,000 | 101,000,000 | 542,000,000 | 521,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from continuing operations | 1,744,000,000 | 1,529,000,000 | 1,931,000,000 | 1,390,000,000 | -2,562,000,000 | 998,000,000 | 3,287,000,000 | 1,285,000,000 | 1,097,000,000 | 962,000,000 | 1,707,000,000 | 1,542,000,000 | 1,500,000,000 | 1,237,000,000 | 1,322,000,000 | 948,000,000 | 1,246,000,000 | 1,262,000,000 | 1,260,000,000 | 1,122,000,000 | 956,000,000 | 1,129,000,000 | 1,011,000,000 | 966,000,000 | 776,000,000 | 1,099,000,000 | 867,000,000 | 816,000,000 | 713,000,000 | 819,000,000 | 822,000,000 | 772,000,000 | 1,023,100,000 | ||||||||||||||||||||||||||||||||||||
| income from discontinued operations, net of tax | 1,000,000 | -250,000 | -1,000,000 | 2,500,000 | 10,000,000 | -1,750,000 | -6,000,000 | -1,000,000 | 1,250,000 | -11,000,000 | -1,000,000 | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from continuing operations attributable to cvs health | 1.34 | 1.17 | 1.49 | 1.36 | -2.52 | 0.98 | 6,479,996.74 | 1.26 | 1.07 | 0.93 | 4,929,996.66 | 1.44 | 4,649,996.69 | 1.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations attributable to cvs health | -9,999.99 | -0.01 | 9,999.99 | 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average basic shares outstanding | 1,312 | 1,319 | 1,309 | 1,301 | 1,302 | 1,068 | 1,114 | 1,157 | 1,165 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average diluted shares outstanding | 1,323 | 1,329 | 1,314 | 1,305 | 1,305 | 1,073 | 1,121 | 1,164 | 1,174 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average shares outstanding | 1,301 | 1,020 | 1,018 | 1,016 | 1,016 | 1,019 | 1,030 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net revenues | 47,269,000,000 | 46,708,000,000 | 45,693,000,000 | 48,385,000,000 | 46,181,000,000 | 45,685,000,000 | 44,514,000,000 | 45,971,000,000 | 44,615,000,000 | 43,725,000,000 | 43,215,000,000 | 41,146,000,000 | 38,644,000,000 | 37,169,000,000 | 36,332,000,000 | 37,055,000,000 | 35,021,000,000 | 34,602,000,000 | 32,689,000,000 | 32,782,000,000 | 31,968,000,000 | 31,248,000,000 | 30,763,000,000 | 31,394,000,000 | 30,227,000,000 | 30,714,000,000 | 30,798,000,000 | 28,317,000,000 | 26,674,000,000 | 26,629,000,000 | 25,880,000,000 | 23,875,000,000 | 24,007,000,000 | 23,760,000,000 | 24,641,900,000 | 24,871,100,000 | 23,393,900,000 | 20,863,400,000 | 21,140,300,000 | 21,326,000,000 | 20,495,200,000 | 20,703,300,000 | 13,184,600,000 | ||||||||||||||||||||||||||
| cost of revenues | 39,941,000,000 | 39,507,000,000 | 38,834,000,000 | 28,934,750,000 | 39,055,000,000 | 38,750,000,000 | 37,934,000,000 | 27,576,000,000 | 37,123,000,000 | 36,710,000,000 | 36,471,000,000 | 23,229,250,000 | 31,983,000,000 | 30,767,000,000 | 30,168,000,000 | 20,894,500,000 | 28,553,000,000 | 28,278,000,000 | 26,747,000,000 | 19,131,750,000 | 25,933,000,000 | 25,412,000,000 | 25,181,000,000 | 18,882,500,000 | 24,580,000,000 | 25,265,000,000 | 25,685,000,000 | 15,944,250,000 | 21,496,000,000 | 21,534,000,000 | 21,129,000,000 | 18,851,000,000 | 18,987,000,000 | 19,014,000,000 | 19,630,200,000 | 19,818,900,000 | 18,645,900,000 | 16,462,800,000 | 16,767,100,000 | 17,033,000,000 | 16,300,000,000 | 16,544,800,000 | 9,835,400,000 | ||||||||||||||||||||||||||
| gross profit | 7,328,000,000 | 7,201,000,000 | 6,859,000,000 | 7,904,000,000 | 7,126,000,000 | 6,935,000,000 | 6,580,000,000 | 7,606,000,000 | 7,492,000,000 | 7,015,000,000 | 6,744,000,000 | 7,301,000,000 | 6,661,000,000 | 6,402,000,000 | 6,164,000,000 | 6,633,000,000 | 6,468,000,000 | 6,324,000,000 | 5,942,000,000 | 6,331,000,000 | 6,035,000,000 | 5,836,000,000 | 5,582,000,000 | 6,297,000,000 | 5,647,000,000 | 5,449,000,000 | 5,113,000,000 | 5,555,000,000 | 5,178,000,000 | 5,095,000,000 | 4,751,000,000 | 5,024,000,000 | 5,020,000,000 | 4,746,000,000 | 5,011,700,000 | 5,052,200,000 | 4,748,000,000 | 4,400,600,000 | 4,373,200,000 | 4,293,000,000 | 4,195,200,000 | 4,158,500,000 | 3,349,200,000 | ||||||||||||||||||||||||||
| yoy | 2.83% | 3.84% | 4.24% | 3.92% | -4.89% | -1.14% | -2.43% | 4.18% | 12.48% | 9.58% | 9.41% | 10.07% | 2.98% | 1.23% | 3.74% | 4.77% | 7.17% | 8.36% | 6.45% | 0.54% | 6.87% | 7.10% | 9.17% | 13.36% | 9.06% | 6.95% | 7.62% | 10.57% | 3.15% | 7.35% | -5.20% | -0.56% | 5.73% | 7.85% | 14.60% | 17.68% | 13.18% | 5.82% | 30.57% | ||||||||||||||||||||||||||||||
| qoq | 1.76% | 4.99% | -13.22% | 10.92% | 2.75% | 5.40% | -13.49% | 1.52% | 6.80% | 4.02% | -7.63% | 9.61% | 4.05% | 3.86% | -7.07% | 2.55% | 2.28% | 6.43% | -6.14% | 4.90% | 3.41% | 4.55% | -11.35% | 11.51% | 3.63% | 6.57% | -7.96% | 7.28% | 1.63% | 7.24% | -5.43% | 0.08% | 5.77% | -5.30% | -0.80% | 6.41% | 7.89% | 0.63% | 1.87% | 2.33% | 0.88% | 24.16% | |||||||||||||||||||||||||||
| gross margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| goodwill impairments | 3,921,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other operating expenses | 4,975,000,000 | 4,867,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| operating profit | 2,353,000,000 | -1,587,000,000 | 1,946,000,000 | 3,108,000,000 | 2,499,000,000 | 2,117,000,000 | 1,793,000,000 | 2,995,000,000 | 2,817,000,000 | 2,350,000,000 | 2,176,000,000 | 2,729,000,000 | 2,331,000,000 | 2,262,000,000 | 2,132,000,000 | 2,321,000,000 | 2,246,000,000 | 2,208,000,000 | 2,024,000,000 | 2,209,000,000 | 2,161,000,000 | 1,968,000,000 | 1,699,000,000 | 2,303,000,000 | 1,814,000,000 | 1,708,000,000 | 1,404,000,000 | 1,957,000,000 | 1,584,000,000 | 1,490,000,000 | 1,311,000,000 | 1,484,000,000 | 1,501,000,000 | 1,410,000,000 | 1,565,900,000 | 1,599,800,000 | 1,377,200,000 | 1,466,200,000 | 1,478,100,000 | 1,370,100,000 | 1,271,100,000 | 1,309,800,000 | 736,500,000 | ||||||||||||||||||||||||||
| net income attributable to noncontrolling interest | -500,000 | -1,000,000 | -1,000,000 | -250,000 | -1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations | -10,000 | -10,000 | -3,000 | -60,000 | -30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-averages shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 1,266 | 1,261 | 1,259 | 1,259 | 1,256 | 1,260 | 1,285 | 1,287 | 1,283 | 1,283 | 1,315 | 1,313 | 1,312 | 1,321 | 1,319 | 1,313 | 1,310 | 1,309 | 1,306 | 1,298 | 1,070 | 1,092 | 1,124 | 1,128 | 1,180 | ||||||||||||||||||||||||||||||||||||||||||||
| diluted | 1,270 | 1,264 | 1,262 | 1,259 | 1,259 | 1,267 | 1,290 | 1,290 | 1,287 | 1,291 | 1,315 | 1,321 | 1,328 | 1,329 | 1,327 | 1,322 | 1,315 | 1,314 | 1,312 | 1,302 | 1,075 | 1,099 | 1,132 | 1,136 | 1,190 | ||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to cvs caremark | 1,261,000,000 | 1,254,000,000 | 1,121,000,000 | 956,000,000 | 1,129,000,000 | 1,006,000,000 | 966,000,000 | 776,000,000 | 1,064,000,000 | 868,000,000 | 816,000,000 | 713,000,000 | 809,000,000 | 821,000,000 | 771,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic earnings per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from continuing operations attributable to cvs caremark | 1,060,000 | 1,040,000 | 910,000 | 780,000 | 910,000 | 800,000 | 760,000 | 600,000 | 840,000 | 650,000 | 600,000 | 520,000 | 600,000 | 610,000 | 560,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations attributable to cvs caremark | -10,000 | -2,500 | 2,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average basic common shares outstanding | 1,218,000,000 | 1,227,000,000 | 1,232,000,000 | 1,265,000,000 | 1,278,000,000 | 1,299,000,000 | 1,332,000,000 | 1,355,000,000 | 1,362,000,000 | 1,360,000,000 | 1,359,000,000 | 1,386,000,000 | 1,429,400,000 | 1,456,900,000 | 1,450,000,000 | 1,435,500,000 | 1,431,800,000 | 1,429,800,000 | 1,473,700,000 | 1,492,400,000 | 906,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| diluted earnings per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average diluted common shares outstanding | 1,226,000,000 | 1,236,000,000 | 1,241,000,000 | 1,274,000,000 | 1,287,000,000 | 1,309,000,000 | 1,340,000,000 | 1,364,000,000 | 1,371,000,000 | 1,368,000,000 | 1,369,000,000 | 1,396,000,000 | 1,444,900,000 | 1,471,800,000 | 1,468,900,000 | 1,469,700,000 | 1,468,700,000 | 1,467,700,000 | 1,521,200,000 | 1,542,500,000 | 939,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| dividends declared per common share | 168,750 | 225,000 | 225,000 | 225,000 | 121,875 | 162,500 | 162,500 | 162,500 | 93,750 | 125,000 | 125,000 | 125,000 | 87,500 | 87,500 | 87,500 | 76,250 | 76,250 | 76,250 | 69,000 | 60,000 | 60,000 | 60,000 | 60,000 | 48,750 | |||||||||||||||||||||||||||||||||||||||||||||
| income from continuing operations before income tax provision | 1,443,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations, net of tax benefit | -1,800,000 | -2,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preference dividends, net of income tax benefit | 3,500,000 | 3,600,000 | 3,500,000 | 3,400,000 | 3,500,000 | 3,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income available to common shareholders | 1,021,300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| earnings from continuing operations before income tax provision | 1,471,900,000 | 1,235,100,000 | 1,353,500,000 | 1,363,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| earnings from continuing operations | 889,100,000 | 743,500,000 | 818,800,000 | 823,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net earnings | 886,500,000 | 738,400,000 | 736,000,000 | 774,800,000 | 748,500,000 | 689,500,000 | 723,600,000 | 408,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net earnings available to common shareholders | 886,500,000 | 738,400,000 | 732,500,000 | 771,200,000 | 745,000,000 | 686,100,000 | 720,100,000 | 405,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total operating expenses | 3,370,800,000 | 2,922,900,000 | 2,612,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations, net of income tax benefit of 3.2 | -5,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations, net of income tax benefit of 52.0 for the thirteen weeks and 82.1 for the thirty-nine weeks | -82,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations, net of tax benefit of 30.1 million | -48,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| earnings before income tax provision | 1,239,200,000 | 1,143,600,000 | 1,203,900,000 | 672,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| selling, general and administrative expenses | 2,403,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| depreciation and amortization | 208,800,000 |
We provide you with 20 years income statements for CVS Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CVS Health stock. Explore the full financial landscape of CVS Health stock with our expertly curated income statements.
The information provided in this report about CVS Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.